FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

FDG-PET in HIV-Positive Patient with Extranodal Diffuse Large B-Cell Lymphoma

Published:2024-04-25 Issue:02 Volume:23 Page:126-129
ISSN:1450-1147
Container-title:World Journal of Nuclear Medicine
language:en
Short-container-title:World J Nucl Med

Author:

Mashriqi Faizullah¹,Keir Graham¹,Vijayashankar Akarsh¹,Glaser Joseph E.²^ORCID,Franceschi Ana M.¹^ORCID

Affiliation:

1. Division of Neuroradiology, Department of Radiology, Northwell Health / Donald and Barbara Zucker School of Medicine, Lenox Hill Hospital, New York, New York, United States

2. Division of Nuclear Medicine, Department of Radiology, Northwell Health / Donald and Barbara Zucker School of Medicine, Manhasset, New York, United States

Abstract

AbstractExtranodal diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease process and an aggressive form of non-Hodgkin's lymphoma. We present a case of multiorgan involvement of DLBCL in a patient with documented risk factors, including [18F] fluorodeoxyglucose positron emission tomography/magnetic resonance imaging findings highlighting striking perineural spread involving intracranial and extracranial segments of the bilateral trigeminal nerves.

Publisher

Georg Thieme Verlag KG

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0044-1779751.pdf

Reference16 articles.

1. Diffuse large B-cell lymphoma;L H Sehn;N Engl J Med,2021

2. Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence;T A Ollila;Curr Treat Options Oncol,2018

3. Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse;D Villa;Haematologica,2011

4. Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era;N Lehners;Leuk Lymphoma,2016

5. Risk of CNS dissemination in extranodal lymphomas;A JM Ferreri;Lancet Oncol,2014